{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:16:12Z","timestamp":1767626172468,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":118,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811687013"},{"type":"electronic","value":"9789811687020"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-981-16-8702-0_11","type":"book-chapter","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T09:02:54Z","timestamp":1649754174000},"page":"171-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Flavivirus Entry Inhibitors"],"prefix":"10.1007","author":[{"given":"Yufeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.peptides.2017.04.002","volume":"92","author":"K Alagarasu","year":"2017","unstructured":"Alagarasu K, Patil PS, Shil P, Seervi M, Kakade MB, Tillu H, Salunke A (2017) In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2. Peptides 92:23\u201330. https:\/\/doi.org\/10.1016\/j.peptides.2017.04.002","journal-title":"Peptides"},{"issue":"6","key":"11_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021658","volume":"6","author":"MM Alen","year":"2011","unstructured":"Alen MM, De Burghgraeve T, Kaptein SJ, Balzarini J, Neyts J, Schols D (2011) Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells. PLoS One 6(6):e21658. https:\/\/doi.org\/10.1371\/journal.pone.0021658","journal-title":"PLoS One"},{"issue":"6","key":"11_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.7150\/ijms.5037","volume":"10","author":"MA Alhoot","year":"2013","unstructured":"Alhoot MA, Rathinam AK, Wang SM, Manikam R, Sekaran SD (2013) Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Int J Med Sci 10(6):719\u2013729. https:\/\/doi.org\/10.7150\/ijms.5037","journal-title":"Int J Med Sci"},{"issue":"19","key":"11_CR4","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.1200566109","volume":"109","author":"R de Alwis","year":"2012","unstructured":"de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE Jr, de Silva AM (2012) Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A 109(19):7439\u20137444. https:\/\/doi.org\/10.1073\/pnas.1200566109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"11_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002930","volume":"8","author":"SK Austin","year":"2012","unstructured":"Austin SK, Dowd KA, Shrestha B, Nelson CA, Edeling MA, Johnson S, Pierson TC, Diamond MS, Fremont DH (2012) Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope. PLoS Pathog 8(10):e1002930. https:\/\/doi.org\/10.1371\/journal.ppat.1002930","journal-title":"PLoS Pathog"},{"issue":"4","key":"11_CR6","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1128\/jvi.01840-06","volume":"81","author":"FW Bai","year":"2007","unstructured":"Bai FW, Town T, Pradhan D, Cox J, Ashish LM, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E (2007) Antiviral peptides targeting the West Nile virus envelope protein. J Virol 81(4):2047\u20132055. https:\/\/doi.org\/10.1128\/jvi.01840-06","journal-title":"J Virol"},{"issue":"7614","key":"11_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","volume":"536","author":"G Barba-Spaeth","year":"2016","unstructured":"Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney MC, Medits I, Sharma A, Simon-Loriere E, Sakuntabhai A, Cao-Lormeau VM, Haouz A, England P, Stiasny K, Mongkolsapaya J, Heinz FX, Screaton GR, Rey FA (2016) Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536(7614):48\u201353. https:\/\/doi.org\/10.1038\/nature18938","journal-title":"Nature"},{"issue":"1","key":"11_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/aac.01429-12","volume":"57","author":"CM Byrd","year":"2013","unstructured":"Byrd CM, Dai D, Grosenbach DW, Berhanu A, Jones KF, Cardwell KB, Schneider C, Wineinger KA, Page JM, Harver C, Stavale E, Tyavanagimatt S, Stone MA, Bartenschlager R, Scaturro P, Hruby DE, Jordan R (2013) A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother 57(1):15\u201325. https:\/\/doi.org\/10.1128\/aac.01429-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"11_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006685","volume":"12","author":"AC Carro","year":"2018","unstructured":"Carro AC, Piccini LE, Damonte EB (2018) Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies. PLoS Negl Trop Dis 12(8):e0006685. https:\/\/doi.org\/10.1371\/journal.pntd.0006685","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"11_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nm0897-866","volume":"3","author":"Y Chen","year":"1997","unstructured":"Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3(8):866\u2013871. https:\/\/doi.org\/10.1038\/nm0897-866","journal-title":"Nat Med"},{"issue":"9","key":"11_CR11","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3390\/ijms18091957","volume":"18","author":"JM Chen","year":"2017","unstructured":"Chen JM, Fan YC, Lin JW, Chen YY, Hsu WL, Chiou SS (2017) Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low-density lipoprotein receptor, and DC-SIGN. Int J Mol Sci 18(9):1957. https:\/\/doi.org\/10.3390\/ijms18091957","journal-title":"Int J Mol Sci"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.3389\/fmicb.2019.03079","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Li Y, Wang X, Zou P (2019) Montelukast, an anti-asthmatic drug, inhibits Zika virus infection by disrupting viral integrity. Front Microbiol 10:3079. https:\/\/doi.org\/10.3389\/fmicb.2019.03079","journal-title":"Front Microbiol"},{"issue":"1","key":"11_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.virol.2008.06.017","volume":"379","author":"YJ Chien","year":"2008","unstructured":"Chien YJ, Chen WJ, Hsu WL, Chiou SS (2008) Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Virology 379(1):143\u2013151. https:\/\/doi.org\/10.1016\/j.virol.2008.06.017","journal-title":"Virology"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-neuro-080317-062231","volume":"42","author":"KM Christian","year":"2019","unstructured":"Christian KM, Song HJ, Ming GL (2019) Pathophysiology and mechanisms of Zika virus infection in the nervous system. Annu Rev Neurosci 42:249\u2013269. https:\/\/doi.org\/10.1146\/annurev-neuro-080317-062231","journal-title":"Annu Rev Neurosci"},{"issue":"Pt 2","key":"11_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1099\/vir.0.80411-0","volume":"86","author":"JJH Chu","year":"2005","unstructured":"Chu JJH, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng ML (2005) Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol 86(Pt 2):405\u2013412. https:\/\/doi.org\/10.1099\/vir.0.80411-0","journal-title":"J Gen Virol"},{"issue":"2","key":"11_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.str.2012.01.001","volume":"20","author":"JJ Cockburn","year":"2012","unstructured":"Cockburn JJ, Navarro Sanchez ME, Fretes N, Urvoas A, Staropoli I, Kikuti CM, Coffey LL, Arenzana Seisdedos F, Bedouelle H, Rey FA (2012) Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. Structure 20(2):303\u2013314. https:\/\/doi.org\/10.1016\/j.str.2012.01.001","journal-title":"Structure"},{"issue":"6","key":"11_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000721","volume":"4","author":"JM Costin","year":"2010","unstructured":"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF (2010) Structural optimization and de novo design of dengue virus entry inhibitory peptides. PLoS Negl Trop Dis 4(6):e721. https:\/\/doi.org\/10.1371\/journal.pntd.0000721","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"11_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/jvi.02273-12","volume":"87","author":"JM Costin","year":"2013","unstructured":"Costin JM, Zaitseva E, Kahle KM, Nicholson CO, Rowe DK, Graham AS, Bazzone LE, Hogancamp G, Figueroa Sierra M, Fong RH, Yang ST, Lin L, Robinson JE, Doranz BJ, Chernomordik LV, Michael SF, Schieffelin JS, Isern S (2013) Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop. J Virol 87(1):52\u201366. https:\/\/doi.org\/10.1128\/jvi.02273-12","journal-title":"J Virol"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.antiviral.2018.04.018","volume":"155","author":"X Cui","year":"2018","unstructured":"Cui X, Wu Y, Fan D, Gao N, Ming Y, Wang P, An J (2018) Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with \u03b23 integrin. Antiviral Res 155:20\u201327. https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.018","journal-title":"Antiviral Res"},{"issue":"5","key":"11_CR20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","volume":"19","author":"L Dai","year":"2016","unstructured":"Dai L, Song J, Lu X, Deng YQ, Musyoki AM, Cheng H, Zhang Y, Yuan Y, Song H, Haywood J, Xiao H, Yan J, Shi Y, Qin CF, Qi J, Gao GF (2016) Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19(5):696\u2013704. https:\/\/doi.org\/10.1016\/j.chom.2016.04.013","journal-title":"Cell Host Microbe"},{"issue":"2","key":"11_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NTH, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR (2015) A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol 16(2):170\u2013177. https:\/\/doi.org\/10.1038\/ni.3058","journal-title":"Nat Immunol"},{"issue":"12","key":"11_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/v8120322","volume":"8","author":"R Delvecchio","year":"2016","unstructured":"Delvecchio R, Higa LM, Pezzuto P, Valadao AL, Garcez PP, Monteiro FL, Loiola EC, Dias AA, Silva FJ, Aliota MT, Caine EA, Osorio JE, Bellio M, O\u2019Connor DH, Rehen S, de Aguiar RS, Savarino A, Campanati L, Tanuri A (2016) Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models. Viruses 8(12):322. https:\/\/doi.org\/10.3390\/v8120322","journal-title":"Viruses"},{"issue":"1","key":"11_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016059","volume":"6","author":"YQ Deng","year":"2011","unstructured":"Deng YQ, Dai JX, Ji GH, Jiang T, Wang HJ, Yang HO, Tan WL, Liu R, Yu M, Ge BX, Zhu QY, Qin ED, Guo YJ, Qin CF (2011) A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS One 6(1):e16059. https:\/\/doi.org\/10.1371\/journal.pone.0016059","journal-title":"PLoS One"},{"issue":"3","key":"11_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.antiviral.2009.05.006","volume":"83","author":"MS Diamond","year":"2009","unstructured":"Diamond MS (2009) Progress on the development of therapeutics against West Nile virus. Antiviral Res 83(3):214\u2013227. https:\/\/doi.org\/10.1016\/j.antiviral.2009.05.006","journal-title":"Antiviral Res"},{"issue":"4","key":"11_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004072","volume":"10","author":"MA Edeling","year":"2014","unstructured":"Edeling MA, Austin SK, Shrestha B, Dowd KA, Mukherjee S, Nelson CA, Johnson S, Mabila MN, Christian EA, Rucker J, Pierson TC, Diamond MS, Fremont DH (2014) Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement. PLoS Pathog 10(4):e1004072. https:\/\/doi.org\/10.1371\/journal.ppat.1004072","journal-title":"PLoS Pathog"},{"issue":"3","key":"11_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12250-013-3331-8","volume":"28","author":"J Fan","year":"2013","unstructured":"Fan J, Liu Y, Xie X, Zhang B, Yuan Z (2013) Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III. Virol Sin 28(3):152\u2013160. https:\/\/doi.org\/10.1007\/s12250-013-3331-8","journal-title":"Virol Sin"},{"issue":"3","key":"11_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/emmm.201303404","volume":"6","author":"G Fibriansah","year":"2014","unstructured":"Fibriansah G, Tan JL, Smith SA, de Alwis AR, Ng TS, Kostyuchenko VA, Ibarra KD, Wang J, Harris E, de Silva A, Crowe JE Jr, Lok SM (2014) A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med 6(3):358\u2013371. https:\/\/doi.org\/10.1002\/emmm.201303404","journal-title":"EMBO Mol Med"},{"issue":"6243","key":"11_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aaa8651","volume":"349","author":"G Fibriansah","year":"2015","unstructured":"Fibriansah G, Ibarra KD, Ng T-S, Smith SA, Tan JL, Lim X-N, Ooi JSG, Kostyuchenko VA, Wang J, de Silva AM, Harris E, Crowe JE, Lok S-M (2015) DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science 349(6243):88\u201391. https:\/\/doi.org\/10.1126\/science.aaa8651","journal-title":"Science"},{"issue":"2","key":"11_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006934","volume":"14","author":"EN Gallichotte","year":"2018","unstructured":"Gallichotte EN, Baric TJ, Yount BL Jr, Widman DG, Durbin A, Whitehead S, Baric RS, de Silva AM (2018) Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes. PLoS Pathog 14(2):e1006934. https:\/\/doi.org\/10.1371\/journal.ppat.1006934","journal-title":"PLoS Pathog"},{"issue":"11","key":"11_CR30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/v11111019","volume":"11","author":"Y Gao","year":"2019","unstructured":"Gao Y, Tai W, Wang N, Li X, Jiang S, Debnath AK, Du L, Chen S (2019) Identification of novel natural products as effective and broad-spectrum anti-Zika virus inhibitors. Viruses 11(11):1019. https:\/\/doi.org\/10.3390\/v11111019","journal-title":"Viruses"},{"issue":"22","key":"11_CR31","doi-asserted-by":"publisher","first-page":"9422","DOI":"10.1073\/pnas.0703498104","volume":"104","author":"AP Goncalvez","year":"2007","unstructured":"Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ (2007) Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci U S A 104(22):9422\u20139427. https:\/\/doi.org\/10.1073\/pnas.0703498104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"14722","DOI":"10.1038\/ncomms14722","volume":"8","author":"SS Hasan","year":"2017","unstructured":"Hasan SS, Miller A, Sapparapu G, Fernandez E, Klose T, Long F, Fokine A, Porta JC, Jiang W, Diamond MS, Crowe JE Jr, Kuhn RJ, Rossmann MG (2017) A human antibody against Zika virus crosslinks the E protein to prevent infection. Nat Commun 8:14722. https:\/\/doi.org\/10.1038\/ncomms14722","journal-title":"Nat Commun"},{"issue":"7158","key":"11_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449(7158):101\u2013104. https:\/\/doi.org\/10.1038\/nature06106","journal-title":"Nature"},{"issue":"23","key":"11_CR34","doi-asserted-by":"publisher","first-page":"e01682","DOI":"10.1128\/JVI.01682-20","volume":"94","author":"AR Hoffmann","year":"2020","unstructured":"Hoffmann AR, Guha S, Wu E, Ghimire J, Wang YL, He J, Garry RF, Wimley WC (2020) Broad-spectrum antiviral entry inhibition by interfacially active peptides. J Virol 94(23):e01682\u2013e01620. https:\/\/doi.org\/10.1128\/JVI.01682-20","journal-title":"J Virol"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1743-422X-2-49","volume":"2","author":"YM Hrobowski","year":"2005","unstructured":"Hrobowski YM, Garry RF, Michael SF (2005) Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J 2:49. https:\/\/doi.org\/10.1186\/1743-422X-2-49","journal-title":"Virol J"},{"issue":"6","key":"11_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007836","volume":"15","author":"D Hu","year":"2019","unstructured":"Hu D, Zhu Z, Li S, Deng Y, Wu Y, Zhang N, Puri V, Wang C, Zou P, Lei C, Tian X, Wang Y, Zhao Q, Li W, Prabakaran P, Feng Y, Cardosa J, Qin C, Zhou X, Dimitrov DS, Ying T (2019) A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III. PLoS Pathog 15(6):e1007836. https:\/\/doi.org\/10.1371\/journal.ppat.1007836","journal-title":"PLoS Pathog"},{"issue":"4","key":"11_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002188","volume":"7","author":"K Ichiyama","year":"2013","unstructured":"Ichiyama K, Gopala Reddy SB, Zhang LF, Chin WX, Muschin T, Heinig L, Suzuki Y, Nanjundappa H, Yoshinaka Y, Ryo A, Nomura N, Ooi EE, Vasudevan SG, Yoshida T, Yamamoto N (2013) Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry\/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application. PLoS Negl Trop Dis 7(4):e2188. https:\/\/doi.org\/10.1371\/journal.pntd.0002188","journal-title":"PLoS Negl Trop Dis"},{"key":"11_CR38","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4021","volume":"5","author":"S Injampa","year":"2017","unstructured":"Injampa S, Muenngern N, Pipattanaboon C, Benjathummarak S, Boonha K, Hananantachai H, Wongwit W, Ramasoota P, Pitaksajjakul P (2017) Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity. Peer J 5:e4021. https:\/\/doi.org\/10.7717\/peerj.4021","journal-title":"Peer J"},{"issue":"8","key":"11_CR39","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.bmcl.2015.02.059","volume":"25","author":"SS Jadav","year":"2015","unstructured":"Jadav SS, Kaptein S, Timiri A, De Burghgraeve T, Badavath VN, Ganesan R, Sinha BN, Neyts J, Leyssen P, Jayaprakash V (2015) Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors. Bioorg Med Chem Lett 25(8):1747\u20131752. https:\/\/doi.org\/10.1016\/j.bmcl.2015.02.059","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"11_CR40","doi-asserted-by":"publisher","first-page":"16785","DOI":"10.3390\/ijms131216785","volume":"13","author":"J Johari","year":"2012","unstructured":"Johari J, Kianmehr A, Mustafa MR, Abubakar S, Zandi K (2012) Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus. Int J Mol Sci 13(12):16785\u201316795. https:\/\/doi.org\/10.3390\/ijms131216785","journal-title":"Int J Mol Sci"},{"issue":"8","key":"11_CR41","doi-asserted-by":"publisher","first-page":"92428","DOI":"10.1172\/jci.insight.92428","volume":"2","author":"YW Kam","year":"2017","unstructured":"Kam YW, Lee CY, Teo TH, Howland SW, Amrun SN, Lum FM, See P, Kng NQ, Huber RG, Xu MH, Tan HL, Choo A, Maurer-Stroh S, Ginhoux F, Fink K, Wang CI, Ng LF, Renia L (2017) Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight 2(8):92428. https:\/\/doi.org\/10.1172\/jci.insight.92428","journal-title":"JCI Insight"},{"issue":"3","key":"11_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","volume":"84","author":"T Kampmann","year":"2009","unstructured":"Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR (2009) In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res 84(3):234\u2013241. https:\/\/doi.org\/10.1016\/j.antiviral.2009.09.007","journal-title":"Antiviral Res"},{"issue":"8","key":"11_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006715","volume":"12","author":"JC Kao","year":"2018","unstructured":"Kao JC, HuangFu WC, Tsai TT, Ho MR, Jhan MK, Shen TJ, Tseng PC, Wang YT, Lin CF (2018) The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR. PLoS Negl Trop Dis 12(8):e0006715. https:\/\/doi.org\/10.1371\/journal.pntd.0006715","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"11_CR44","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1128\/aac.00686-10","volume":"54","author":"SJ Kaptein","year":"2010","unstructured":"Kaptein SJ, De Burghgraeve T, Froeyen M, Pastorino B, Alen MM, Mondotte JA, Herdewijn P, Jacobs M, de Lamballerie X, Schols D, Gamarnik AV, Sztaricskai F, Neyts J (2010) A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro. Antimicrob Agents Chemother 54(12):5269\u20135280. https:\/\/doi.org\/10.1128\/aac.00686-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"11_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.antiviral.2010.09.002","volume":"88","author":"D Kato","year":"2010","unstructured":"Kato D, Era S, Watanabe I, Arihara M, Sugiura N, Kimata K, Suzuki Y, Morita K, Hidari KI, Suzuki T (2010) Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein. Antiviral Res 88(2):236\u2013243. https:\/\/doi.org\/10.1016\/j.antiviral.2010.09.002","journal-title":"Antiviral Res"},{"issue":"6","key":"11_CR46","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.celrep.2018.10.031","volume":"25","author":"JR Keeffe","year":"2018","unstructured":"Keeffe JR, Van Rompay KKA, Olsen PC, Wang Q, Gazumyan A, Azzopardi SA, Schaefer-Babajew D, Lee YE, Stuart JB, Singapuri A, Watanabe J, Usachenko J, Ardeshir A, Saeed M, Agudelo M, Eisenreich T, Bournazos S, Oliveira TY, Rice CM, Coffey LL, MacDonald MR, Bjorkman PJ, Nussenzweig MC, Robbiani DF (2018) A combination of two human monoclonal antibodies prevents Zika virus escape mutations in non-human primates. Cell Rep 25(6):1385\u20131394.e1387. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.031","journal-title":"Cell Rep"},{"key":"11_CR47","first-page":"747","volume-title":"Fields virology","author":"DM Knipe","year":"2013","unstructured":"Knipe DM, Howley PM (2013) Fields virology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 747\u2013756","edition":"6"},{"issue":"5","key":"11_CR48","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","volume":"108","author":"RJ Kuhn","year":"2002","unstructured":"Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108(5):717\u2013725. https:\/\/doi.org\/10.1016\/S0092-8674(02)00660-8","journal-title":"Cell"},{"key":"11_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.micro.62.081307.163005","volume":"62","author":"JL Kyle","year":"2008","unstructured":"Kyle JL, Harris E (2008) Global spread and persistence of dengue. Annu Rev Microbiol 62:71\u201392. https:\/\/doi.org\/10.1146\/annurev.micro.62.081307.163005","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"11_CR50","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41598-020-80596-4","volume":"11","author":"SH Lee","year":"2021","unstructured":"Lee SH, Kim EH, O\u2019Neal JT, Dale G, Holthausen DJ, Bowen JR, Quicke KM, Skountzou I, Gopal S, George S, Wrammert J, Suthar MS, Jacob J (2021) The amphibian peptide Yodha is virucidal for Zika and dengue viruses. Sci Rep 11(1):602. https:\/\/doi.org\/10.1038\/s41598-020-80596-4","journal-title":"Sci Rep"},{"issue":"15","key":"11_CR51","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1021\/jm800412d","volume":"51","author":"Z Li","year":"2008","unstructured":"Li Z, Khaliq M, Zhou Z, Post CB, Kuhn RJ, Cushman M (2008) Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins. J Med Chem 51(15):4660\u20134671. https:\/\/doi.org\/10.1021\/jm800412d","journal-title":"J Med Chem"},{"issue":"Pt 10","key":"11_CR52","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1099\/vir.0.055178-0","volume":"94","author":"XQ Li","year":"2013","unstructured":"Li XQ, Qiu LW, Chen Y, Wen K, Cai JP, Chen J, Pan YX, Li J, Hu DM, Huang YF, Liu LD, Ding XX, Guo YH, Che XY (2013) Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design. J Gen Virol 94(Pt 10):2191\u20132201. https:\/\/doi.org\/10.1099\/vir.0.055178-0","journal-title":"J Gen Virol"},{"issue":"3","key":"11_CR53","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.immuni.2017.02.012","volume":"46","author":"C Li","year":"2017","unstructured":"Li C, Deng YQ, Wang S, Ma F, Aliyari R, Huang XY, Zhang NN, Watanabe M, Dong HL, Liu P, Li XF, Ye Q, Tian M, Hong S, Fan J, Zhao H, Li L, Vishlaghi N, Buth JE, Au C, Liu Y, Lu N, Du P, Qin FX, Zhang B, Gong D, Dai X, Sun R, Novitch BG, Xu Z, Qin CF, Cheng G (2017) 25-Hydroxycholesterol protects host against Zika virus infection and its associated microcephaly in a mouse model. Immunity 46(3):446\u2013456. https:\/\/doi.org\/10.1016\/j.immuni.2017.02.012","journal-title":"Immunity"},{"issue":"5","key":"11_CR54","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.celrep.2018.04.005","volume":"23","author":"C Li","year":"2018","unstructured":"Li C, Gao F, Yu L, Wang R, Jiang Y, Shi X, Yin C, Tang X, Zhang F, Xu Z, Zhang L (2018a) A single injection of human neutralizing antibody protects against Zika virus infection and microcephaly in developing mouse embryos. Cell Rep 23(5):1424\u20131434. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.005","journal-title":"Cell Rep"},{"issue":"1","key":"11_CR55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.str.2017.11.017","volume":"26","author":"J Li","year":"2018","unstructured":"Li J, Watterson D, Chang CW, Che XY, Li XQ, Ericsson DJ, Qiu LW, Cai JP, Chen J, Fry SR, Cheung STM, Cooper MA, Young PR, Kobe B (2018b) Structural and functional characterization of a cross-reactive dengue virus neutralizing antibody that recognizes a cryptic epitope. Structure 26(1):51\u201359. https:\/\/doi.org\/10.1016\/j.str.2017.11.017","journal-title":"Structure"},{"issue":"1","key":"11_CR56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1074\/jbc.RA118.005015","volume":"294","author":"F Li","year":"2019","unstructured":"Li F, Lang Y, Ji Z, Xia Z, Han Y, Cheng Y, Liu G, Sun F, Zhao Y, Gao M, Chen Z, Wu Y, Li W, Cao Z (2019) A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles. J Biol Chem 294(1):182\u2013194. https:\/\/doi.org\/10.1074\/jbc.RA118.005015","journal-title":"J Biol Chem"},{"key":"11_CR57","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fmicb.2020.00242","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Zhang D, Li C, Zheng Z, Fu M, Ni F, Liu Y, Du T, Wang H, Griffin GE, Zhang M, Hu Q (2020) Characterization of Zika virus endocytic pathways in human glioblastoma cells. Front Microbiol 11:242. https:\/\/doi.org\/10.3389\/fmicb.2020.00242","journal-title":"Front Microbiol"},{"issue":"9","key":"11_CR58","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1021\/acsinfecdis.8b00127","volume":"4","author":"W Lian","year":"2018","unstructured":"Lian W, Jang J, Potisopon S, Li PC, Rahmeh A, Wang J, Kwiatkowski NP, Gray NS, Yang PL (2018) Discovery of immunologically inspired small molecules that target the viral envelope protein. ACS Infect Dis 4(9):1395\u20131406. https:\/\/doi.org\/10.1021\/acsinfecdis.8b00127","journal-title":"ACS Infect Dis"},{"issue":"1","key":"11_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/med.1026","volume":"22","author":"J Liu","year":"2002","unstructured":"Liu J, Thorp SC (2002) Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev 22(1):1\u201325. https:\/\/doi.org\/10.1002\/med.1026","journal-title":"Med Res Rev"},{"issue":"11","key":"11_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050995","volume":"7","author":"SM Lok","year":"2012","unstructured":"Lok SM, Costin JM, Hrobowski YM, Hoffmann AR, Rowe DK, Kukkaro P, Holdaway H, Chipman P, Fontaine KA, Holbrook MR, Garry RF, Kostyuchenko V, Wimley WC, Isern S, Rossmann MG, Michael SF (2012) Release of dengue virus genome induced by a peptide inhibitor. PLoS One 7(11):e50995. https:\/\/doi.org\/10.1371\/journal.pone.0050995","journal-title":"PLoS One"},{"issue":"5","key":"11_CR61","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1073\/pnas.1815432116","volume":"116","author":"F Long","year":"2019","unstructured":"Long F, Doyle M, Fernandez E, Miller AS, Klose T, Sevvana M, Bryan A, Davidson E, Doranz BJ, Kuhn RJ, Diamond MS, Crowe JE Jr, Rossmann MG (2019) Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope. Proc Natl Acad Sci U S A 116(5):1591\u20131596. https:\/\/doi.org\/10.1073\/pnas.1815432116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR62","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3389\/fmicb.2018.01214","volume":"9","author":"J Lu","year":"2018","unstructured":"Lu J, Wang R, Xia B, Yu Y, Zhou X, Yang Z, Huang P (2018) Potent neutralization ability of a human monoclonal antibody against serotype 1 dengue virus. Front Microbiol 9:1214. https:\/\/doi.org\/10.3389\/fmicb.2018.01214","journal-title":"Front Microbiol"},{"key":"11_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ebiom.2019.08.060","volume":"47","author":"A Martinez-Lopez","year":"2019","unstructured":"Martinez-Lopez A, Persaud M, Chavez MP, Zhang H, Rong L, Liu S, Wang TT, Sarafianos SG, Diaz-Griffero F (2019) Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus. EBioMedicine 47:269\u2013283. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.060","journal-title":"EBioMedicine"},{"issue":"2","key":"11_CR64","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.celrep.2016.12.045","volume":"18","author":"L Meertens","year":"2017","unstructured":"Meertens L, Labeau A, Dejarnac O, Cipriani S, Sinigaglia L, Bonnet-Madin L, Le Charpentier T, Hafirassou ML, Zamborlini A, Cao-Lormeau VM, Coulpier M, Misse D, Jouvenet N, Tabibiazar R, Gressens P, Schwartz O, Amara A (2017) Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses. Cell Rep 18(2):324\u2013333. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.045","journal-title":"Cell Rep"},{"issue":"12","key":"11_CR65","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","volume":"100","author":"Y Modis","year":"2003","unstructured":"Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100(12):6986\u20136991. https:\/\/doi.org\/10.1073\/pnas.0832193100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6972","key":"11_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Y Modis","year":"2004","unstructured":"Modis Y, Ogata S, Clements D, Harrison SC (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427(6972):313\u2013319. https:\/\/doi.org\/10.1038\/nature02165","journal-title":"Nature"},{"issue":"1","key":"11_CR67","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","volume":"78","author":"TP Monath","year":"2008","unstructured":"Monath TP (2008) Treatment of yellow fever. Antiviral Res 78(1):116\u2013124. https:\/\/doi.org\/10.1016\/j.antiviral.2007.10.009","journal-title":"Antiviral Res"},{"key":"11_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2017.11.009","volume":"514","author":"JMC Monteiro","year":"2018","unstructured":"Monteiro JMC, Oliveira MD, Dias RS, Nacif-Mar\u00e7al L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO (2018) The antimicrobial peptide HS-1 inhibits dengue virus infection. Virology 514:79\u201387. https:\/\/doi.org\/10.1016\/j.virol.2017.11.009","journal-title":"Virology"},{"issue":"Pt 7","key":"11_CR69","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1099\/vir.0.18883-0","volume":"84","author":"M Nawa","year":"2003","unstructured":"Nawa M, Takasaki T, Yamada KI, Kurane I, Akatsuka T (2003) Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. J Gen Virol 84(Pt 7):1737\u20131741. https:\/\/doi.org\/10.1099\/vir.0.18883-0","journal-title":"J Gen Virol"},{"issue":"1","key":"11_CR70","doi-asserted-by":"publisher","first-page":"9805","DOI":"10.1038\/s41598-018-27855-7","volume":"8","author":"RLS Neris","year":"2018","unstructured":"Neris RLS, Figueiredo CM, Higa LM, Araujo DF, Carvalho CAM, Vercoza BRF, Silva MOL, Carneiro FA, Tanuri A, Gomes AMO, Bozza MT, Da Poian AT, Cruz-Oliveira C, Assuncao-Miranda I (2018) Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope. Sci Rep 8(1):9805. https:\/\/doi.org\/10.1038\/s41598-018-27855-7","journal-title":"Sci Rep"},{"issue":"1","key":"11_CR71","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/22221751.2019.1614885","volume":"8","author":"X Niu","year":"2019","unstructured":"Niu X, Zhao L, Qu L, Yao Z, Zhang F, Yan Q, Zhang S, Liang R, Chen P, Luo J, Xu W, Lv H, Liu X, Lei H, Yi C, Li P, Wang Q, Wang Y, Yu L, Zhang X, Bryan LA, Davidson E, Doranz JB, Feng L, Pan W, Zhang F, Chen L (2019) Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model. Emerg Microbes Infect 8(1):749\u2013759. https:\/\/doi.org\/10.1080\/22221751.2019.1614885","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"11_CR72","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cbdd.12576","volume":"86","author":"A Panya","year":"2015","unstructured":"Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT (2015) A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Chem Biol Drug Des 86(5):1093\u20131104. https:\/\/doi.org\/10.1111\/cbdd.12576","journal-title":"Chem Biol Drug Des"},{"issue":"11","key":"11_CR73","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/v12111267","volume":"12","author":"A Panya","year":"2020","unstructured":"Panya A, Sawasdee N, Songprakhon P, Tragoolpua Y, Rotarayanont S, Choowongkomon K, Yenchitsomanus PT (2020) A synthetic bioactive peptide derived from the asian medicinal plant acacia catechu binds to dengue virus and inhibits cell entry. Viruses 12(11):1267. https:\/\/doi.org\/10.3390\/v12111267","journal-title":"Viruses"},{"key":"11_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104813","volume":"179","author":"Y Qi","year":"2020","unstructured":"Qi Y, Han L, Qi Y, Jin X, Zhang B, Niu J, Zhong J, Xu Y (2020) Anti-flavivirus activity of polyoxometalate. Antiviral Res 179:104813. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104813","journal-title":"Antiviral Res"},{"key":"11_CR75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41421-019-0140-8","volume":"6","author":"P Qu","year":"2020","unstructured":"Qu P, Zhang C, Li M, Ma W, Xiong P, Liu Q, Zou G, Lavillette D, Yin F, Jin X, Huang Z (2020) A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein. Cell Discov 6:5. https:\/\/doi.org\/10.1038\/s41421-019-0140-8","journal-title":"Cell Discov"},{"key":"11_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.antiviral.2015.10.012","volume":"124","author":"R Ramadhany","year":"2015","unstructured":"Ramadhany R, Hirai I, Sasaki T, Ono K, Ramasoota P, Ikuta K, Kurosu T (2015) Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection. Antiviral Res 124:61\u201368. https:\/\/doi.org\/10.1016\/j.antiviral.2015.10.012","journal-title":"Antiviral Res"},{"issue":"3","key":"11_CR77","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","volume":"18","author":"K Rausch","year":"2017","unstructured":"Rausch K, Hackett BA, Weinbren NL, Reeder SM, Sadovsky Y, Hunter CA, Schultz DC, Coyne CB, Cherry S (2017) Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active against Zika virus. Cell Rep 18(3):804\u2013815. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.068","journal-title":"Cell Rep"},{"issue":"47","key":"11_CR78","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.1073\/pnas.1508095112","volume":"112","author":"AS Richard","year":"2015","unstructured":"Richard AS, Zhang A, Park SJ, Farzan M, Zong M, Choe H (2015) Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proc Natl Acad Sci U S A 112(47):14682\u201314687. https:\/\/doi.org\/10.1073\/pnas.1508095112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2018.02.003","volume":"152","author":"AE Rocker","year":"2018","unstructured":"Rocker AE, Muller JA, Dietzel E, Harms M, Kruger F, Heid C, Sowislok A, Riber CF, Kupke A, Lippold S, von Einem J, Beer J, Knoll B, Becker S, Schmidt-Chanasit J, Otto M, Vapalahti O, Zelikin AN, Bitan G, Schrader T, Munch J (2018) The molecular tweezer CLR01 inhibits Ebola and Zika virus infection. Antiviral Res 152:26\u201335. https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.003","journal-title":"Antiviral Res"},{"issue":"6","key":"11_CR80","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/v11060524","volume":"11","author":"C Sabino","year":"2019","unstructured":"Sabino C, Basic M, Bender D, Elgner F, Himmelsbach K, Hildt E (2019) Bafilomycin A1 and U18666A efficiently impair ZIKV infection. Viruses 11(6):524. https:\/\/doi.org\/10.3390\/v11060524","journal-title":"Viruses"},{"issue":"19","key":"11_CR81","doi-asserted-by":"publisher","first-page":"11540","DOI":"10.1128\/jvi.01745-14","volume":"88","author":"P Scaturro","year":"2014","unstructured":"Scaturro P, Trist IM, Paul D, Kumar A, Acosta EG, Byrd CM, Jordan R, Brancale A, Bartenschlager R (2014) Characterization of the mode of action of a potent dengue virus capsid inhibitor. J Virol 88(19):11540\u201311555. https:\/\/doi.org\/10.1128\/jvi.01745-14","journal-title":"J Virol"},{"issue":"4","key":"11_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000851","volume":"6","author":"AG Schmidt","year":"2010","unstructured":"Schmidt AG, Yang PL, Harrison SC (2010a) Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 6(4):e1000851. https:\/\/doi.org\/10.1371\/journal.ppat.1000851","journal-title":"PLoS Pathog"},{"issue":"24","key":"11_CR83","doi-asserted-by":"publisher","first-page":"12549","DOI":"10.1128\/JVI.01440-10","volume":"84","author":"AG Schmidt","year":"2010","unstructured":"Schmidt AG, Yang PL, Harrison SC (2010b) Peptide inhibitors of flavivirus entry derived from the E protein stem. J Virol 84(24):12549\u201312554. https:\/\/doi.org\/10.1128\/JVI.01440-10","journal-title":"J Virol"},{"issue":"4","key":"11_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002627","volume":"8","author":"AG Schmidt","year":"2012","unstructured":"Schmidt AG, Lee K, Yang PL, Harrison SC (2012) Small-molecule inhibitors of dengue-virus entry. PLoS Pathog 8(4):e1002627. https:\/\/doi.org\/10.1371\/journal.ppat.1002627","journal-title":"PLoS Pathog"},{"issue":"12","key":"11_CR85","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/v12121346","volume":"12","author":"M Sevvana","year":"2020","unstructured":"Sevvana M, Rogers TF, Miller AS, Long F, Klose T, Beutler N, Lai YC, Parren M, Walker LM, Buda G, Burton DR, Rossmann MG, Kuhn RJ (2020) Structural basis of Zika virus specific neutralization in subsequent Flavivirus infections. Viruses 12(12):1346. https:\/\/doi.org\/10.3390\/v12121346","journal-title":"Viruses"},{"issue":"Pt A","key":"11_CR86","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ijbiomac.2017.06.105","volume":"104","author":"N Sharma","year":"2017","unstructured":"Sharma N, Murali A, Singh SK, Giri R (2017) Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein. Int J Biol Macromol 104(Pt A):1046\u20131054. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.06.105","journal-title":"Int J Biol Macromol"},{"key":"11_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104876","volume":"182","author":"N Sharma","year":"2020","unstructured":"Sharma N, Prosser O, Kumar P, Tuplin A, Giri R (2020) Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein. Antiviral Res 182:104876. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104876","journal-title":"Antiviral Res"},{"issue":"3","key":"11_CR88","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/19420862.2016.1148850","volume":"8","author":"X Shi","year":"2016","unstructured":"Shi X, Deng Y, Wang H, Ji G, Tan W, Jiang T, Li X, Zhao H, Xia T, Meng Y, Wang C, Yu X, Yang Y, Li B, Qin ED, Dai J, Qin CF, Guo Y (2016) A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion. MAbs 8(3):574\u2013584. https:\/\/doi.org\/10.1080\/19420862.2016.1148850","journal-title":"MAbs"},{"issue":"4","key":"11_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000823","volume":"6","author":"B Shrestha","year":"2010","unstructured":"Shrestha B, Brien JD, Sukupolvi-Petty S, Austin SK, Edeling MA, Kim T, O\u2019Brien KM, Nelson CA, Johnson S, Fremont DH, Diamond MS (2010) The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog 6(4):e1000823. https:\/\/doi.org\/10.1371\/journal.ppat.1000823","journal-title":"PLoS Pathog"},{"issue":"Pt 2","key":"11_CR90","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1099\/00221287-148-2-361","volume":"148","author":"Y Sun","year":"2002","unstructured":"Sun Y, Zhou X, Liu J, Bao K, Zhang G, Tu G, Kieser T, Deng Z (2002) \u2018Streptomyces nanchangensis\u2019, a producer of the insecticidal polyether antibiotic nanchangmycin and the antiparasitic macrolide meilingmycin, contains multiple polyketide gene clusters. Microbiology (Reading) 148(Pt 2):361\u2013371. https:\/\/doi.org\/10.1099\/00221287-148-2-361","journal-title":"Microbiology (Reading)"},{"issue":"2","key":"11_CR91","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.chom.2016.07.002","volume":"20","author":"T Tabata","year":"2016","unstructured":"Tabata T, Petitt M, Puerta-Guardo H, Michlmayr D, Wang C, Fang-Hoover J, Harris E, Pereira L (2016) Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission. Cell Host Microbe 20(2):155\u2013166. https:\/\/doi.org\/10.1016\/j.chom.2016.07.002","journal-title":"Cell Host Microbe"},{"issue":"7","key":"11_CR92","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/jmv.24457","volume":"88","author":"LB Talarico","year":"2016","unstructured":"Talarico LB, Damonte EB (2016) Characterization of in vitro dengue virus resistance to carrageenan. J Med Virol 88(7):1120\u20131129. https:\/\/doi.org\/10.1002\/jmv.24457","journal-title":"J Med Virol"},{"key":"11_CR93","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","volume":"143","author":"CW Tan","year":"2017","unstructured":"Tan CW, Sam IC, Chong WL, Lee VS, Chan YF (2017) Polysulfonate suramin inhibits Zika virus infection. Antiviral Res 143:186\u2013194. https:\/\/doi.org\/10.1016\/j.antiviral.2017.04.017","journal-title":"Antiviral Res"},{"issue":"139","key":"11_CR94","doi-asserted-by":"publisher","first-page":"139ra183","DOI":"10.1126\/scitranslmed.3003888","volume":"4","author":"EP Teoh","year":"2012","unstructured":"Teoh EP, Kukkaro P, Teo EW, Lim AP, Tan TT, Yip A, Schul W, Aung M, Kostyuchenko VA, Leo YS, Chan SH, Smith KG, Chan AH, Zou G, Ooi EE, Kemeny DM, Tan GK, Ng JK, Ng ML, Alonso S, Fisher D, Shi PY, Hanson BJ, Lok SM, MacAry PA (2012) The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med 4(139):139ra183. https:\/\/doi.org\/10.1126\/scitranslmed.3003888","journal-title":"Sci Transl Med"},{"issue":"14","key":"11_CR95","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1073\/pnas.2000414117","volume":"117","author":"KKA Van Rompay","year":"2020","unstructured":"Van Rompay KKA, Coffey LL, Kapoor T, Gazumyan A, Keesler RI, Jurado A, Peace A, Agudelo M, Watanabe J, Usachenko J, Singapuri A, Immareddy R, Ardeshir A, Stuart JB, Bournazos S, Ravetch JV, Balderes PJ, Lorenz IC, Esswein SR, Keeffe JR, Bjorkman PJ, Wang Q, Rice CM, MacDonald MR, Nussenzweig MC, Robbiani DF (2020) A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques. Proc Natl Acad Sci U S A 117(14):7981\u20137989. https:\/\/doi.org\/10.1073\/pnas.2000414117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR96","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3389\/fmicb.2017.01314","volume":"8","author":"A Vazquez-Calvo","year":"2017","unstructured":"Vazquez-Calvo A, Jimenez de Oya N, Martin-Acebes MA, Garcia-Moruno E, Saiz JC (2017) Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses West Nile virus, Zika virus, and dengue virus. Front Microbiol 8:1314. https:\/\/doi.org\/10.3389\/fmicb.2017.01314","journal-title":"Front Microbiol"},{"issue":"8","key":"11_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074035","volume":"8","author":"P Vervaeke","year":"2013","unstructured":"Vervaeke P, Alen M, Noppen S, Schols D, Oreste P, Liekens S (2013) Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III. PLoS One 8(8):e74035. https:\/\/doi.org\/10.1371\/journal.pone.0074035","journal-title":"PLoS One"},{"issue":"9","key":"11_CR98","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1021\/acsinfecdis.5b00066","volume":"1","author":"QY Wang","year":"2015","unstructured":"Wang QY, Shi PY (2015) Flavivirus entry inhibitors. ACS Infect Dis 1(9):428\u2013434. https:\/\/doi.org\/10.1021\/acsinfecdis.5b00066","journal-title":"ACS Infect Dis"},{"issue":"5","key":"11_CR99","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","volume":"123","author":"LH Wang","year":"1993","unstructured":"Wang LH, Rothberg KG, Anderson RG (1993) Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123(5):1107\u20131117. https:\/\/doi.org\/10.1083\/jcb.123.5.1107","journal-title":"J Cell Biol"},{"issue":"5","key":"11_CR100","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/AAC.01148-08","volume":"53","author":"QY Wang","year":"2009","unstructured":"Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG (2009) A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother 53(5):1823\u20131831. https:\/\/doi.org\/10.1128\/AAC.01148-08","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.141","volume":"6","author":"AY Wang","year":"2017","unstructured":"Wang AY, Thurmond S, Islas L, Hui KY, Hai R (2017a) Zika virus genome biology and molecular pathogenesis. Emerg Microbes Infect 6:e13. https:\/\/doi.org\/10.1038\/emi.2016.141","journal-title":"Emerg Microbes Infect"},{"key":"11_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.002","volume":"171 (1):229-241","author":"J Wang","year":"2017","unstructured":"Wang J, Bardelli M, Espinosa DA, Pedotti M, Ng TS, Bianchi S, Simonelli L, Lim EXY, Foglierini M, Zatta F, Jaconi S, Beltramello M, Cameroni E, Fibriansah G, Shi J, Barca T, Pagani I, Rubio A, Broccoli V, Vicenzi E, Graham V, Pullan S, Dowall S, Hewson R, Jurt S, Zerbe O, Stettler K, Lanzavecchia A, Sallusto F, Cavalli A, Harris E, Lok SM, Varani L, Corti D (2017b) A human bi-specific antibody against Zika virus with high therapeutic potential. Cell 171 (1):229-241:e215. https:\/\/doi.org\/10.1016\/j.cell.2017.09.002","journal-title":"Cell"},{"key":"11_CR103","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.virusres.2018.06.009","volume":"253","author":"CY Wang","year":"2018","unstructured":"Wang CY, Hour MJ, Lai HC, Chen CH, Chang PJ, Huang SH, Lin CW (2018) Epigallocatechin-3-gallate inhibits the early stages of Japanese encephalitis virus infection. Virus Res 253:140\u2013146. https:\/\/doi.org\/10.1016\/j.virusres.2018.06.009","journal-title":"Virus Res"},{"key":"11_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.02.062","volume":"26 (12):3360-33","author":"L Wang","year":"2019","unstructured":"Wang L, Wang R, Wang L, Ben H, Yu L, Gao F, Shi X, Yin C, Zhang F, Xiang Y, Zhang L (2019a) Structural basis for neutralization and protection by a Zika virus-specific human antibody. Cell Rep 26 (12):3360-3368:e3365. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.062","journal-title":"Cell Rep"},{"issue":"11","key":"11_CR105","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/v11111064","volume":"11","author":"X Wang","year":"2019","unstructured":"Wang X, Xia S, Zou P, Lu L (2019b) Erythromycin estolate inhibits Zika virus infection by blocking viral entry as a viral inactivator. Viruses 11(11):1064. https:\/\/doi.org\/10.3390\/v11111064","journal-title":"Viruses"},{"key":"11_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104673","volume":"174","author":"J Wei","year":"2020","unstructured":"Wei J, Hameed M, Wang X, Zhang J, Guo S, Anwar MN, Pang L, Liu K, Li B, Shao D, Qiu Y, Zhong D, Zhou B, Ma Z (2020) Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo. Antiviral Res 174:104673. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104673","journal-title":"Antiviral Res"},{"key":"11_CR107","unstructured":"WHO (2021) Dengue and severe dengue. Accessed 2021\/5\/28. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue"},{"key":"11_CR108","doi-asserted-by":"publisher","first-page":"(8):1006-1016 e","DOI":"10.1016\/j.chembiol.2018.05.011","volume":"25","author":"M de Wispelaere","year":"2018","unstructured":"de Wispelaere M, Lian W, Potisopon S, Li PC, Jang J, Ficarro SB, Clark MJ, Zhu X, Kaplan JB, Pitts JD, Wales TE, Wang J, Engen JR, Marto JA, Gray NS, Yang PL (2018) Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein. Cell Chem Biol 25:(8):1006-1016 e1008. https:\/\/doi.org\/10.1016\/j.chembiol.2018.05.011","journal-title":"Cell Chem Biol"},{"key":"11_CR109","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3389\/fmicb.2020.01871","volume":"11","author":"M Xing","year":"2020","unstructured":"Xing M, Ji M, Hu J, Zhu T, Chen Y, Bai X, Mwangi J, Mo G, Lai R, Jin L (2020) Snake cathelicidin derived peptide inhibits Zika virus infection. Front Microbiol 11:1871. https:\/\/doi.org\/10.3389\/fmicb.2020.01871","journal-title":"Front Microbiol"},{"issue":"10","key":"11_CR110","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nm.4184","volume":"22","author":"M Xu","year":"2016","unstructured":"Xu M, Lee EM, Wen Z, Cheng Y, Huang WK, Qian X, Tcw J, Kouznetsova J, Ogden SC, Hammack C, Jacob F, Nguyen HN, Itkin M, Hanna C, Shinn P, Allen C, Michael SG, Simeonov A, Huang W, Christian KM, Goate A, Brennand KJ, Huang R, Xia M, Ming GL, Zheng W, Song H, Tang H (2016) Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat Med 22(10):1101\u20131107. https:\/\/doi.org\/10.1038\/nm.4184","journal-title":"Nat Med"},{"key":"11_CR111","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41541-016-0003-3","volume":"2","author":"M Xu","year":"2017","unstructured":"Xu M, Zuest R, Velumani S, Tukijan F, Toh YX, Appanna R, Tan EY, Cerny D, MacAry P, Wang CI, Fink K (2017) A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus. NPJ Vaccines 2:2. https:\/\/doi.org\/10.1038\/s41541-016-0003-3","journal-title":"NPJ Vaccines"},{"issue":"12","key":"11_CR112","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/v12121475","volume":"12","author":"M Yamamoto","year":"2020","unstructured":"Yamamoto M, Ichinohe T, Watanabe A, Kobayashi A, Zhang R, Song J, Kawaguchi Y, Matsuda Z, Inoue JI (2020) The antimalarial compound atovaquone inhibits Zika and dengue virus infection by blocking E protein-mediated membrane fusion. Viruses 12(12):1475. https:\/\/doi.org\/10.3390\/v12121475","journal-title":"Viruses"},{"issue":"12","key":"11_CR113","doi-asserted-by":"publisher","first-page":"93042","DOI":"10.1172\/jci.insight.93042","volume":"2","author":"L Yu","year":"2017","unstructured":"Yu L, Wang R, Gao F, Li M, Liu J, Wang J, Hong W, Zhao L, Wen Y, Yin C, Wang H, Zhang Q, Li Y, Zhou P, Zhang R, Liu Y, Tang X, Guan Y, Qin CF, Chen L, Shi X, Jin X, Cheng G, Zhang F, Zhang L (2017a) Delineating antibody recognition against Zika virus during natural infection. JCI Insight 2(12):93042. https:\/\/doi.org\/10.1172\/jci.insight.93042","journal-title":"JCI Insight"},{"key":"11_CR114","doi-asserted-by":"publisher","first-page":"15672","DOI":"10.1038\/ncomms15672","volume":"8","author":"Y Yu","year":"2017","unstructured":"Yu Y, Deng YQ, Zou P, Wang Q, Dai Y, Yu F, Du L, Zhang NN, Tian M, Hao JN, Meng Y, Li Y, Zhou X, Fuk-Woo Chan J, Yuen KY, Qin CF, Jiang S, Lu L (2017b) A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat Commun 8:15672. https:\/\/doi.org\/10.1038\/ncomms15672","journal-title":"Nat Commun"},{"key":"11_CR115","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1038\/ncomms13679","volume":"7","author":"S Zhang","year":"2016","unstructured":"Zhang S, Kostyuchenko VA, Ng TS, Lim XN, Ooi JSG, Lambert S, Tan TY, Widman DG, Shi J, Baric RS, Lok SM (2016) Neutralization mechanism of a highly potent antibody against Zika virus. Nat Commun 7:13679. https:\/\/doi.org\/10.1038\/ncomms13679","journal-title":"Nat Commun"},{"issue":"7","key":"11_CR116","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/v12070727","volume":"12","author":"J Zhao","year":"2020","unstructured":"Zhao J, Chen J, Li M, Chen M, Sun C (2020) Multifaceted functions of CH25H and 25HC to modulate the lipid metabolism, immune responses, and broadly antiviral activities. Viruses 12(7):727. https:\/\/doi.org\/10.3390\/v12070727","journal-title":"Viruses"},{"issue":"12","key":"11_CR117","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/cb800176t","volume":"3","author":"Z Zhou","year":"2008","unstructured":"Zhou Z, Khaliq M, Suk JE, Patkar C, Li L, Kuhn RJ, Post CB (2008) Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. ACS Chem Biol 3(12):765\u2013775. https:\/\/doi.org\/10.1021\/cb800176t","journal-title":"ACS Chem Biol"},{"key":"11_CR118","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.antiviral.2014.01.011","volume":"104","author":"X Zu","year":"2014","unstructured":"Zu X, Liu Y, Wang S, Jin R, Zhou Z, Liu H, Gong R, Xiao G, Wang W (2014) Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III. Antiviral Res 104:7\u201314. https:\/\/doi.org\/10.1016\/j.antiviral.2014.01.011","journal-title":"Antiviral Res"}],"container-title":["Advances in Experimental Medicine and Biology","Virus Entry Inhibitors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-16-8702-0_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T09:34:03Z","timestamp":1649756043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-16-8702-0_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9789811687013","9789811687020"],"references-count":118,"URL":"https:\/\/doi.org\/10.1007\/978-981-16-8702-0_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"13 April 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}